AISHA KHAN: Open Payments
NPI 1871270751 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $277 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $109 |
| Exact Sciences Corporation | 5 | $107 |
| ABBVIE INC. | 4 | $87 |
| Astellas Pharma US Inc | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Insmed, Inc. | 1 | $25 |
Products named: Kerendia, Cologuard Collection Kit, Ozempic, VRAYLAR, Veozah, CAPLYTA, FARXIGA, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
